Effectdossier · gearchiveerd kwartaal
ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Gevolgde houders
+1Δ houders
7.96MGehouden aandelen
$95.31MGerapporteerde waarde
+2Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +6.7% ·
aandelenstroom -12.3% ·
netto nieuwe posities +6.2%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | — |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | — | — |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | — | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | — | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | — |
| Q2 2024 | 9 | — | 3.87M | $50.19M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 948.08K | -35.0% | $11.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 493.19K | +1.5% | $5.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 493.19K | +1.5% | $5.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 479.60K | +2.1% | $5.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passief) | 471.99K | +0.4% | $5.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 300.00K | Nieuw | $3.59M | 0.0% | New | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Marshall Wace ✦ | 275.39K | -67.9% | $3.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | Marshall Wace ✦ | 275.39K | -67.9% | $3.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 225.74K | -20.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 166.43K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 166.43K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 60.72K | -22.6% | $726,842 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 10.15K | Nieuw | $122,000 | 0.0% | New | 1 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 1.78K | -0.3% | $21,363 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 1.78K | -0.3% | $21,363 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $3.59M | 0.0% |
| T. Rowe Price | $122,000 | 0.0% |
Verlaten
| Citadel Advisors | $447,129 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 131 houders, 26.72M aandelen, $290.62M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 14
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 14
SC 13G/A — Deep Track Capital, LP
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API